Investor Briefing with James McDonnell
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Shareholder Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Shareholder Briefing with CEO James McDonnell CEO James McDonnell, held a shareholder briefing...
Prescient Therapeutics: Q&A Update with Dr James Campbell Reach Markets recently interviewed Dr James Campbell...
Prescient Therapeutics: Investor Briefing with CEO James McDonnell CEO and Managing Director, James McDonnell, held...
This content is password-protected. To view it, please enter the password below. Password:
Prescient Therapeutics: Mariam Mansour, PhD Mariam Mansour, PhD, Director of Clinical Development and Translational Sciences...
Prescient Therapeutics: Professor H. Miles Prince Professor H. Miles Prince AM, the Principal Investigator for...
Prescient Therapeutics: Investor Briefing with CEO and Managing Director, Steven Yatomi-Clarke CEO and Managing Director,...

This investor centre was built by Reach Markets
©2025 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.